3 ms·
But for an insurance company, the ROI on curing someone’s hemophilia may be very very large. On the more consumer side of things, being able to fix some sort o
by MBCook 9y ago
But for an insurance company, the ROI on curing someone’s hemophilia may be very very large.
On the more consumer side of things, being able to fix some sort of obnoxious but perfectly survivable condition that genetic engineering may be able to solve (say lactose intolerant) may be something that you could sell to a lot of people.
- kgwgk 9y agoFrom the POV of an insurance company, the patient might go elsewhere in a few years and they would only partially benefit from a cure.
- MBCook 9y agoTrue. Well, for young people. For Medicare or certain people on Medicaid it might be worth it.
- brokencode 9y agoSurely an insurance company would prefer that the patient go elsewhere rather than have to pay $100,000+ every year on treatment. Even if they lose a customer, at least they don’t have that enormous expense.